Study of the Prevalence of Iron Deficiency in Patients With Heart Failure
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,300
- 主要终点
- Complete blood iron status
研究概览
简要总结
Despite its known prevalence in Heart Failure, a recent study conducted by Prof. Cacoub (unpublished) on the French national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In chronic diseases including Heart Failure, Transferrin Saturation Factor is only performed in about 10% of cases while it is recommended for patients with Heart Failure (French Health High Authority 2011). The purpose of this study is to obtain current data on the prevalence of iron deficiency in France in patients with Heart Failure, applying the recommendations of European Society of Cardiology and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient, male or female, over 18 years of age
- •Patient present at the hospital on the day of the study
- •Diagnosis of Heart Failure (acute or chronic) regardless of left ventricular ejection fraction (LVEF)
- •Patient with signed consent
排除标准
- •Protected patient: major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision
- •Pregnant or breastfeeding woman
研究组 & 干预措施
HEART FAILURE
Patients with Heart Failure diagnosis
干预措施: Iron status testing (Diagnostic Test)
结局指标
主要结局
Complete blood iron status
时间窗: One day
ferritin, Transferrin Saturation Factor
次要结局
未报告次要终点